| Podiatry Center Of Eastern Ct, Llc | |
|
360 Tolland Tpke Ste 2c, Manchester, CT 06042-1770 | |
| (860) 647-7727 | |
| (860) 647-7559 |
| Full Name | Podiatry Center Of Eastern Ct, Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 360 Tolland Tpke Ste 2c, Manchester, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144453895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 000769 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Podiatry Center Of Eastern Ct, Llc 360 Tolland Tpke Ste 2c, Manchester, CT 06042-1770 Ph: (860) 647-7727 | Podiatry Center Of Eastern Ct, Llc 360 Tolland Tpke Ste 2c, Manchester, CT 06042-1770 Ph: (860) 647-7727 |
News Archive
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
With the support of its 2.6 million members in New York, AARP is calling on the U.S. Senate to stand with the overwhelming majority of Americans and vote to give Medicare the power to negotiate for lower prescription drug prices.
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
› Verified 2 days ago
Hartford Healthcare Medical Group, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 29 Haynes St, Manchester, CT 06040 Phone: 860-547-0616 | |
Marcella A Macdonald, D.P.M. Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 153 Main Street, Suite 12, Manchester, CT 06042 Phone: 860-649-9797 Fax: 860-432-9294 | |
Hartford Specialists Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 29 Haynes St, Manchester, CT 06040 Phone: 860-547-0616 Fax: 860-524-2655 | |
N/a Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 483 Middle Tpke W, Manchester, CT 06040 Phone: 860-646-5153 Fax: 860-647-0449 | |
Dr. Donna M. Boccelli, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 116 E Center St, Suite 10, Manchester, CT 06040 Phone: 860-647-7727 Fax: 860-647-7559 | |
Dr. Kenneth Lee Wichman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 117 E Center St, Manchester, CT 06040 Phone: 860-649-3338 Fax: 860-646-4938 |